The U.S. Food and Drug Administration launched an investigation into whether the blood pressure medication Benicar increases the risk of heart-related deaths, Reuters reports.
According to the story, the agency is evaluating clinical data from two drug trials. In both of them, diabetes patients who took the drug had a higher rate of death from heart-related causes than patients taking a placebo.
Benicar, the brand name for the drug known chemically ...
continue reading...